Labshake search
Citations for R&D Systems :
1 - 50 of 262 citations for 9 Z 12 E OCTADECADIENOIC ACID METHYL ESTER since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Evolutionary Biology 2023Quote: Caspase-8 inhibitor Z-IETD-FMK and Caspase-9 inhibitor Z-LEHD-FMK were obtained from R&D Systems and were dissolved in dimethyl sulfoxide (DMSO ...
-
bioRxiv - Immunology 2021Quote: ... Caffeic acid phenethyl ester (CAPE) (R&D Systems), Mitoquinone (MitoQ ...
-
bioRxiv - Immunology 2022Quote: ... or caspase-9 inhibitors (50 μM Z-LEHD-FMK, R&D Systems), respectively ...
-
bioRxiv - Molecular Biology 2023Quote: ... and Fluorogenic Peptide Substrate VII: Z-Leu-Arg-4-methyl-7-coumarylamide (Z-LR-AMC)(Catalog # ES008) were purchased from R&D Systems (Minneapolis, MN, USA). The enzyme reactions were initiated upon addition of ice-cold of hrCTSL (96pM ...
-
bioRxiv - Cell Biology 2023Quote: ... 9-cis retinoic acid and all-trans retinoic acid (both R&D Systems) were each dissolved in 100% DMSO ...
-
bioRxiv - Cell Biology 2021Quote: ... 40 μM Z-VAD-FMK (Z-VAD, R&D Systems) and 10 μM Necrostatin-7 (Nec-7 ...
-
bioRxiv - Cancer Biology 2022Quote: ... live/dead stained and incubated with recombinant human Siglec-9 Fc chimera (#1139-SL-050) or recombinant mouse Siglec-E Fc chimera (#5806-SL-050) both from R&D systems, USA for 20 min on ice ...
-
Caspase cleavage of Influenza A virus M2 disrupts M2-LC3 interaction and regulates virion productionbioRxiv - Microbiology 2024Quote: ... Z-VEID-FMK (R&D systems; FMK006), Z-DEVD-FMK (R&D systems FMK004) ...
-
Caspase cleavage of Influenza A virus M2 disrupts M2-LC3 interaction and regulates virion productionbioRxiv - Microbiology 2024Quote: ... Z-DEVD-FMK (R&D systems FMK004), and Z-IETD (Invivogen ...
-
bioRxiv - Cancer Biology 2023Quote: ... Concentration of active MMP9 on 200μg of total proteins lysate was quantified by using a Human Active MMP-9 Fluorokine E assay kit (F9M00; R&D Systems, Noyal Châtillon sur Seiche, France) according to the protocol provided by the manufacturer ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 μM z-VAD-fmk (zVAD) (R&D Systems) and 5 μM necrosulfonamide (NSA ...
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human MMP-9 protein and Recombinant mice MMP-9 protein were purchased from R&D systems. Commercialized DENV2-NS1 protein were purchased from Native Antigen ...
-
bioRxiv - Immunology 2021Quote: ... ZVAD-fmk (20 μM, Z-VAD-FMK, R&D Systems), 911 (1 μM ...
-
bioRxiv - Biochemistry 2019Quote: ... Cathepsins substrate (Z-FR-AMC) was from R&D Systems and legumain substrate (Z-AAN-AMC ...
-
bioRxiv - Immunology 2022Quote: ... caspase-8 (50 μM Z-IETD-FMK, R&D Systems) or caspase-9 inhibitors (50 μM Z-LEHD-FMK ...
-
bioRxiv - Immunology 2023Quote: ... Z-VAD-FMK (ZVAD, 001) was from R&D Systems. Z-DEVD-FMK was obtained from APExBIO ...
-
bioRxiv - Cell Biology 2019Quote: ... E-cadherin (R&D Systems) and BSA (Fisher) ...
-
bioRxiv - Immunology 2022Quote: ... The functionalized tips were then dipped in different hIL-9 or mIL-9 (both from R&D systems) concentrations ...
-
bioRxiv - Neuroscience 2019Quote: ... MMP-9 (R&D Systems; Minneapolis, MN), IL-6 (Invitrogen Carlsbad ...
-
bioRxiv - Bioengineering 2020Quote: ... and S10-Z was incubated with recombinant KLK2 (R&D Systems). Following pre-cleavage with recombinant enzymes ...
-
bioRxiv - Bioengineering 2020Quote: ... and S18-Z were incubated with recombinant KLK14 (R&D Systems); and S10-Z was incubated with recombinant KLK2 (R&D Systems) ...
-
bioRxiv - Cancer Biology 2022Quote: ... The caspase 4 inhibitor (Z-YVAD-FMK, FMK005, R&D systems) was used in further experiments at the dose of 50 µM ...
-
bioRxiv - Neuroscience 2020Quote: ... or E (R&D Systems, Inc.). Conditioned media from triplicate culture conditions was collected after 48 hours and human CXCL5 levels measured using a human CXCL5 Quantikine Elisa Kit (R&D Systems ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems) at 20 μg/ml ...
-
bioRxiv - Molecular Biology 2023Quote: ... 9 ng/ml Activin A (R&D Systems), 5 ng/ml FGF-2 (R&D Systems ...
-
bioRxiv - Immunology 2024Quote: ... and mouse IL-9 (#DY409, R&D Systems).
-
bioRxiv - Cancer Biology 2021Quote: ... and 1μM Caspase-8 Inhibitor Z-IETD-FMK (R&D Systems #FMK007) or the corresponding controls (0.15% DMSO and PBS 0.5% BSA (Roche #10735086001)) ...
-
bioRxiv - Microbiology 2021Quote: Stocks of the cell death inhibitors Z-VAD-FMK (R&D Systems), GSK’963 (Selleck Chemicals) ...
-
bioRxiv - Bioengineering 2020Quote: ... and S20-Z AZPs were incubated with recombinant PRSS3 (R&D Systems); S5-Z ...
-
bioRxiv - Developmental Biology 2022Quote: ... injected at E16.5 with z-VAD-fmk (R&D Systems, Cat #FMK001) at 5 μg/g body weight in 10% DMSO in PBS ...
-
bioRxiv - Immunology 2022Quote: Llamas were immunized intramuscularly once per week over six weeks with carrier free recombinant human IL-9 or mouse IL-9 (R&D Systems). Each llama (4 in total ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-E-cadherin (R&D Systems, AF648), and anti-Snail (NEB ...
-
bioRxiv - Neuroscience 2023Quote: ... and E-selectin (R&D systems, DY575), were measured using DuoSet® enzyme-linked immunosorbent assay (ELISA ...
-
bioRxiv - Molecular Biology 2024Quote: ... E-cadherin (R&D Systems Minneapolis, MN) and collagen1 (Abcam Waltham ...
-
bioRxiv - Cancer Biology 2021Quote: ... Galectin-9 primary antibody (R&D systems, AF-2045) was added to sections at 1 μg/mL dilution and incubated overnight at 4 °C ...
-
bioRxiv - Bioengineering 2021Quote: ... and FGF-9 (200 ng·ml-1, R&D Systems). By day 7 ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... For experiments with Z-VAD-fmk (R&D Systems, Inc., FMK001, Wiesbaden, Germany) cells were pre-treated with 20μM Z-VAD-fmk for 16h ...
-
bioRxiv - Bioengineering 2020Quote: ... primary antibodies (E-cadherin, AF648, R&D Systems, 20 μg/mL ...
-
bioRxiv - Bioengineering 2021Quote: ... primary antibodies (E-cadherin, AF748, R&D Systems, 4 μg/mL ...
-
bioRxiv - Immunology 2023Quote: ... goat anti-E-cadherin (R&D Systems AF748); rabbit anti-E-cadherin (Cell Signaling Technologies 3195) ...
-
bioRxiv - Bioengineering 2023Quote: ... CD62E-FITC (E-Selectin, BBA21, R&D Systems), CD54 (ICAM-1 ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v ...
-
bioRxiv - Immunology 2020Quote: ... MMP-9 Duoset ELISA was obtained from R&D Systems, Inc ...
-
bioRxiv - Microbiology 2021Quote: ... the fluorogenic substrate Z-Leu-Arg-AMC (R&D Systems, Minneapolis, MN, Unites States) was added at a concentration of 25 μM in a final assay volume of 200 μL ...
-
Direct intracellular visualization of Ebola virus-receptor interaction by in situ proximity ligationbioRxiv - Microbiology 2020Quote: ... incubated with the fluorogenic peptide substrate Z-FR-AMC (150 μM; R&D Systems) and measured at a fluorometer following a 0 to 30 min incubation (ƛEx = 390 nm ...
-
bioRxiv - Microbiology 2022Quote: ... Gels were then subjected to immunoblot analysis for CHIKV E using an anti-E antibody (1:1000, R&D Systems, MAB97792SP).
-
bioRxiv - Pharmacology and Toxicology 2022Quote: ... Human 26S Proteasome Protein (E-365) and Human 20S Proteasome Protein (E-360) were purchased from R&D Systems (Minneapolis, MN, USA). Human KRAS (G12D ...
-
bioRxiv - Bioengineering 2023Quote: ... labeled with Alexa Fluor 488, Cat. #IC7619G) and anti-E-Cad (E- cadherin, Cat. #MAB18382, from mouse) were obtained from R&D systems. Anti-Vim (Vimentin ...